Factors influencing TET2 function. It was recently described that restoring TET function via inducible shRNA model of TET-induced AML, or through vitamin C administration, the latter being a cofactor for α-KG dependent dioxygenases reverses leukemogenicity induced by the mutant TET protein [189]. The gene discussed is TET2; the disease is acute myeloid leukemia.